Last reviewed · How we verify
IDP-118 Monad HP Lotion — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
IDP-118 Monad HP Lotion (IDP-118 Monad HP Lotion) — Bausch Health Americas, Inc..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| IDP-118 Monad HP Lotion TARGET | IDP-118 Monad HP Lotion | Bausch Health Americas, Inc. | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- IDP-118 Monad HP Lotion CI watch — RSS
- IDP-118 Monad HP Lotion CI watch — Atom
- IDP-118 Monad HP Lotion CI watch — JSON
- IDP-118 Monad HP Lotion alone — RSS
Cite this brief
Drug Landscape (2026). IDP-118 Monad HP Lotion — Competitive Intelligence Brief. https://druglandscape.com/ci/idp-118-monad-hp-lotion. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab